| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/10/2002 | WO2001070175A3 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 01/10/2002 | WO2001059071A3 Methods of preparing and using a viral vector library |
| 01/10/2002 | WO2001056993A3 Pyrazole compositions useful as inhibitors of erk |
| 01/10/2002 | WO2001052855A3 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone |
| 01/10/2002 | WO2001045548A3 Surgical needle with weeping tip and method of use |
| 01/10/2002 | WO2001044455A3 Antisense oligonucleotides for the inhibition of expression of type i procollagen |
| 01/10/2002 | WO2001043697A3 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| 01/10/2002 | WO2001042192A3 Vla-4 integrin antagonists |
| 01/10/2002 | WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 01/10/2002 | WO2001038344A3 Modulation of signal transduction |
| 01/10/2002 | WO2001037785A3 Novel methods and compositions involving opioids and antagonists thereof |
| 01/10/2002 | WO2001036425A3 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 01/10/2002 | WO2001034604A3 Adenosine receptor antagonists and methods of making and using the same |
| 01/10/2002 | WO2001034603A3 Bicyclic and tricyclic heteroaromatic compounds |
| 01/10/2002 | WO2001032616A3 Oxetanone derivatives |
| 01/10/2002 | WO2001028494A3 Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 01/10/2002 | WO2001025410A3 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 01/10/2002 | WO2001021191A3 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 01/10/2002 | WO2001000615A8 Respiratory syncytial virus replication inhibitors |
| 01/10/2002 | US20020004594 Phosphoramidates and methods therefor |
| 01/10/2002 | US20020004584 HIV immune adjuvant therapy |
| 01/10/2002 | US20020004580 Polypeptide; for use in the diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004531 Nitrone inhibition of cancer development |
| 01/10/2002 | US20020004529 Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| 01/10/2002 | US20020004514 Anticancer compound and enantiomer separation method useful for synthesizing said compound |
| 01/10/2002 | US20020004513 Azacyclic compounds |
| 01/10/2002 | US20020004510 Compounds for treating fibromyalgia and chronic fatigue syndrome |
| 01/10/2002 | US20020004508 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/10/2002 | US20020004503 Viricides |
| 01/10/2002 | US20020004501 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders |
| 01/10/2002 | US20020004500 Drug mixture for cardiovascular disorders |
| 01/10/2002 | US20020004498 Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| 01/10/2002 | US20020004494 Muscular disorders, gastrointestinal disorders, respiratory system disorders |
| 01/10/2002 | US20020004492 Polypeptides; wound healing agent, antiinflammatory agent |
| 01/10/2002 | US20020004478 Pharmaceutical formulations for igf/igfbp |
| 01/10/2002 | US20020004209 Detecting modulators of transcription; incubate cell containing human androgen and estrogen receptors, preferential protein and modulator, monitor cell for adjustment in transcriptional activity |
| 01/10/2002 | US20020004194 Detecting modulators of proteins associated with ionic mobility; obtain cell, incubate with amyloid protein, monitor cells for reduced ionic mobility |
| 01/10/2002 | US20020004049 Tryptophan source from plants and uses therfor |
| 01/10/2002 | US20020004046 Includes use of neutralizing antibody, high affinity antibodies, and viricide (ribavirin, amantadine, rimantadine, or a neuraminidase inhibitor); useful for controlling/treating respiratory syncytial virus in young children |
| 01/10/2002 | US20020004044 Methods for inducing the differentiation of monocytes into functional dendritic cells |
| 01/10/2002 | US20020004043 Cellular and animal models for diseases associated with altered mitochondrial function |
| 01/10/2002 | US20020004040 Complementary adenoviral vector systems and cell lines |
| 01/10/2002 | DE10031971A1 Polymorphe Formen/Hydrate von N-[4-(3-Chlor-4-fluor-phenylamino)-7-(3-morpholin-4-yl-propoxy)-chinazolin-6-yl]-acrylamid Dihydrochlorid, Verfahren zu ihrer Herstellung sowie die Verwendung derselben zur Herstellung von Medikamenten mit irreversibler Tyrosinkinasehemmwirkung Polymorphic forms / hydrates of N- [4- (3-chloro-4-fluoro-phenylamino) -7- (3-morpholin-4-yl-propoxy) -quinazolin-6-yl] -acrylamide dihydrochloride, processes for their preparation and to the use thereof for the preparation of medicaments with irreversible Tyrosinkinasehemmwirkung |
| 01/10/2002 | DE10031932A1 Calpain-Protease 12 Calpain protease 12 |
| 01/10/2002 | DE10031585A1 2-Aminoalkyl-thieno[2,3-d]pyrimidine 2-aminoalkyl-thieno [2,3-d] pyrimidines |
| 01/10/2002 | DE10031584A1 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine 5-aminoalkyl-pyrazolo [4,3-d] pyrimidines |
| 01/10/2002 | DE10029671A1 Biotransformation von biologisch aktiven Verindungen aus verschiedenen chemischen Stoffklassen mittels der Enzyme Laccase und Manganperoxidase Biotransformation of biologically active Verindungen from different classes of chemical substances by means of enzymes laccase and manganese peroxidase |
| 01/10/2002 | CA2630062A1 Methods for treating graft versus host disease and immune disorders associated with rejection using a soluble ctla4 molecule |
| 01/10/2002 | CA2416292A1 Transgenic mice containing targeted gene disruptions |
| 01/10/2002 | CA2415123A1 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | CA2415088A1 Aza-bridged-bicyclic amino acid derivatives as .alpha.4 integrin antagonists |
| 01/10/2002 | CA2415037A1 Glucocortiocoid-selective antiinflammatory agents |
| 01/10/2002 | CA2414976A1 Gpr14 antagonistic agent |
| 01/10/2002 | CA2414881A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | CA2414807A1 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | CA2414799A1 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | CA2414672A1 Novel human serine-threonine kinase |
| 01/10/2002 | CA2414650A1 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 01/10/2002 | CA2414596A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | CA2414592A1 Calpain protease 12 |
| 01/10/2002 | CA2414468A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 01/10/2002 | CA2414461A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | CA2414375A1 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
| 01/10/2002 | CA2413802A1 Substituted-triazolopyrimidines as anticancer agents |
| 01/10/2002 | CA2413756A1 Dna encoding human serine protease d-g |
| 01/10/2002 | CA2413753A1 Antifungal compounds and methods of use |
| 01/10/2002 | CA2413715A1 Grf2-binding proteins and applications thereof |
| 01/10/2002 | CA2413262A1 B7-like molecules and uses thereof |
| 01/10/2002 | CA2413245A1 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 01/10/2002 | CA2413243A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/10/2002 | CA2413186A1 Extracellular matrix and cell adhesion molecules |
| 01/10/2002 | CA2413166A1 Acid-modified arabinogalactan protein composition |
| 01/10/2002 | CA2413128A1 Transporters and ion channels |
| 01/10/2002 | CA2413002A1 Novel pyrazinone derivatives |
| 01/10/2002 | CA2412874A1 Pyrones as inhibitors of cyclooxygenase-2 |
| 01/10/2002 | CA2412872A1 Protein modification and maintenance molecules |
| 01/10/2002 | CA2412845A1 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 01/10/2002 | CA2412839A1 Use of secretin-receptor ligands in treatment of cystic fibrosis (cf) and chronic obstructive pulmonary disease (copd) |
| 01/10/2002 | CA2412836A1 Peptide composition for treatment of periodontal diseases and prevention of skin aging |
| 01/10/2002 | CA2412775A1 Antibodies to human mcp-1 |
| 01/10/2002 | CA2412287A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/10/2002 | CA2412270A1 Pyrrole derivatives for treating aids |
| 01/10/2002 | CA2410972A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410953A1 Adenylyl and guanylyl cyclases |
| 01/10/2002 | CA2410945A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/10/2002 | CA2410680A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410679A1 Secretion and trafficking molecules |
| 01/10/2002 | CA2410658A1 Pyrroloquinolones as antiviral agents |
| 01/10/2002 | CA2406649A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/09/2002 | EP1170594A2 Methods for the identification of compounds useful for the treatment of disease states mediated by Prostaglandin D2 |
| 01/09/2002 | EP1170289A2 Retroviral protease inhibiting compounds |
| 01/09/2002 | EP1170281A1 1,1- and 1,2-disubstituted cyclopropanes, process for their preparation and pharmaceutical compositions thereof |
| 01/09/2002 | EP1170017A1 Use of tumor necrosis factor alpha (TNF-alpha) and vascular endothelial growth factor (VEGF) for the manufacture of a therapeutic composition |
| 01/09/2002 | EP1170015A1 Use of extracts of the fungus Grifola frondosa |
| 01/09/2002 | EP1170012A1 Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside rb 1? |
| 01/09/2002 | EP1170009A2 Thiazolybenzofuran derivatives and their use as SRS-A and leukotiene antagonists |
| 01/09/2002 | EP1170008A1 Valproic acid and derivatives thereof as histone deacetylase inhibitors |
| 01/09/2002 | EP1170007A1 Remedies |
| 01/09/2002 | EP1169475A1 Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy |
| 01/09/2002 | EP1169470A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto |